Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Folia Med (Plovdiv) ; 66(1): 26-34, 2024 Feb 29.
Artigo em Inglês | MEDLINE | ID: mdl-38426462

RESUMO

INTRODUCTION: Tuberculosis is an infectious disease that continues to plague the world today, causing concerns due to its high mortality rate. The therapy regimens used for the treatment of tuberculosis today have demonstrated high efficacy and safety, potentially reducing the disease's burden, but the use of some standardized medications has caused many resistances to emerge. Over the last decade, researchers have been looking for suitable alternatives, with quinolones emerging as the most promising candidate due to their efficacy, safety, and availability. However, their efficacy as a first-line treatment remains debatable.


Assuntos
Quinolonas , Tuberculose Pulmonar , Humanos , Quinolonas/efeitos adversos , Tuberculose Pulmonar/tratamento farmacológico
2.
Neurosurg Rev ; 46(1): 239, 2023 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-37697174

RESUMO

Chronic subdural hematoma (CSDH) is a disease commonly found in the elderly and not a typical finding in pediatric population. History of shunt surgery, child abuse, and blood disorder are some of the common causes of pediatric CSDH (pCSDH). There is growing evidence about the role of middle meningeal artery embolization (MMAE) to manage CSDH in the elderly population with a high risk of rebleeding. However, the evidence in the pediatric population is still sparse. A systematic literature search was conducted on PubMed, Scopus, and Web of Science database from January, 2023, to March, 2023. Search strings were generated based on the combination of modified search terms, such as CSDH, MMA embolization, and child. Risk of bias was assessed using the Cochrane Risk of Bias in Nonrandomized Study for Intervention. Nine articles were included in this review. The success rate of MMA embolization in pediatric CSDH was 88.8%. Histories of ventriculoperitoneal shunt, blood coagulation disorder, and trauma were the causes of CSDH. Time to achieve success was varied from 2 to 9 months. No study with low risk of bias was found. This systematic review found no high-quality evidence regarding the role of MMA embolization in the management of pCSDH. However, due to its high success rate, MMAE could be a promising approach to treat pCSDH.


Assuntos
Embolização Terapêutica , Hematoma Subdural Crônico , Criança , Humanos , Bases de Dados Factuais , Hematoma Subdural Crônico/cirurgia , Artérias Meníngeas/cirurgia , Derivação Ventriculoperitoneal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA